Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of HLA phenotype with response to active specific immunotherapy of melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jul 1992

Mitchell M S, Harel W, Groshen S

Abstract excerpt

PURPOSE: Only a proportion of patients with disseminated melanoma who were immunized successfully with a therapeutic melanoma vaccine (theraccine) had a major clinical response. We investigated whether there was a correlation between their HLA phenotypes and the likelihood of a clinical response. PATIENTS AND METHODS: Seventy patients with disseminated melanoma who were treated with melanoma theraccine were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, MHC Class I

Share to Lymphocytes

Share to Melanoma

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 1607920
DOI: 10.1200/JCO.1992.10.7.1158

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Association of HLA phenotype with response to active specific immunotherapy of melanoma.PMID 1607920Read ↗

Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?Semantic proximity Read ↗

HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2.Semantic proximity Read ↗

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.Semantic proximity Read ↗

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2).Semantic proximity Read ↗

Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells.Semantic proximity Read ↗

A preclinical model to assess the antigenicity of an HLA-A2 melanoma cell vaccine.Semantic proximity Read ↗

HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccine.Semantic proximity Read ↗

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.Semantic proximity Read ↗

Alteration of melanoma cell phenotype following in vitro culturing and exposure to cytostatic agents.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.